Beyond diet and exercise: another option for patients with obesity and polycystic ovary syndrome?
- PMID: 35798656
- DOI: 10.1016/j.fertnstert.2022.06.001
Beyond diet and exercise: another option for patients with obesity and polycystic ovary syndrome?
Comment on
-
Liraglutide 3 mg on weight, body composition, and hormonal and metabolic parameters in women with obesity and polycystic ovary syndrome: a randomized placebo-controlled-phase 3 study.Fertil Steril. 2022 Aug;118(2):371-381. doi: 10.1016/j.fertnstert.2022.04.027. Epub 2022 Jun 13. Fertil Steril. 2022. PMID: 35710599 Clinical Trial.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
